14.02.2023 - 16.02.2023Hyatt Regency Boston, One Ave. de Lafayette, Massachusetts, 02111 Boston, USA
Time: 08:00 to 19:00
Temi della conferenza Welcome to the 2nd mRNA Analytical Development Summit: Trailblazing Advanced Analytics for Superior mRNA Therapeutics and Vaccines
Uniting 80+ Senior Scientists, Directors, and Heads of Analytical Development, Quality Control, CMC and Regulatory - join us in Boston alongside pioneering speakers from innovative biopharma and KOLs of academia.
Speakers: Andrew Geall Co-Founder and Chief Development Officer Replicate Bioscience, Curtis Dobrowolski Co-Founder Nava Therapeutics, Daniel Anderson Professor MIT, and more